HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,637 | +4.7% | 74,087 | -0.5% | 0.02% | +14.3% |
| Q2 2023 | $6,340 | +2.6% | 74,464 | -0.3% | 0.01% | 0.0% |
| Q1 2023 | $6,178 | +5.1% | 74,664 | -0.1% | 0.01% | 0.0% |
| Q4 2022 | $5,880 | -99.9% | 74,764 | +9.4% | 0.01% | +7.7% |
| Q3 2022 | $5,058,000 | +16.0% | 68,325 | +2.1% | 0.01% | +18.2% |
| Q2 2022 | $4,362,000 | +3.3% | 66,916 | +0.1% | 0.01% | +22.2% |
| Q1 2022 | $4,224,000 | +19.2% | 66,816 | 0.0% | 0.01% | +28.6% |
| Q4 2021 | $3,544,000 | -17.7% | 66,816 | +9.6% | 0.01% | -22.2% |
| Q3 2021 | $4,305,000 | +8.8% | 60,979 | +2.7% | 0.01% | +12.5% |
| Q2 2021 | $3,958,000 | -40.0% | 59,387 | 0.0% | 0.01% | -42.9% |
| Q1 2021 | $6,593,000 | -11.0% | 59,387 | -4.8% | 0.01% | -12.5% |
| Q4 2020 | $7,408,000 | +34.2% | 62,387 | -1.4% | 0.02% | +23.1% |
| Q3 2020 | $5,522,000 | -16.9% | 63,287 | -14.7% | 0.01% | -23.5% |
| Q2 2020 | $6,644,000 | -10.1% | 74,187 | 0.0% | 0.02% | -22.7% |
| Q1 2020 | $7,393,000 | -24.0% | 74,187 | -12.4% | 0.02% | -4.3% |
| Q4 2019 | $9,731,000 | -9.4% | 84,687 | -0.6% | 0.02% | -14.8% |
| Q3 2019 | $10,745,000 | +2.8% | 85,187 | -2.0% | 0.03% | +3.8% |
| Q2 2019 | $10,456,000 | +23.0% | 86,887 | -10.6% | 0.03% | +18.2% |
| Q1 2019 | $8,502,000 | -12.7% | 97,187 | -0.2% | 0.02% | -21.4% |
| Q4 2018 | $9,744,000 | -13.6% | 97,387 | -1.1% | 0.03% | +7.7% |
| Q3 2018 | $11,277,000 | +27.6% | 98,421 | -0.1% | 0.03% | +18.2% |
| Q2 2018 | $8,836,000 | +11.3% | 98,524 | -9.2% | 0.02% | +15.8% |
| Q1 2018 | $7,940,000 | +26.0% | 108,526 | 0.0% | 0.02% | +26.7% |
| Q4 2017 | $6,303,000 | +38.6% | 108,526 | +7.1% | 0.02% | +36.4% |
| Q3 2017 | $4,546,000 | +13.6% | 101,326 | 0.0% | 0.01% | +10.0% |
| Q2 2017 | $4,001,000 | -2.7% | 101,326 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $4,111,000 | +0.9% | 101,326 | 0.0% | 0.01% | -9.1% |
| Q4 2016 | $4,073,000 | +11.0% | 101,326 | 0.0% | 0.01% | +10.0% |
| Q3 2016 | $3,669,000 | +24.9% | 101,326 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $2,937,000 | -17.1% | 101,326 | 0.0% | 0.01% | -11.1% |
| Q1 2016 | $3,544,000 | +8.5% | 101,326 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $3,267,000 | -0.2% | 101,326 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $3,275,000 | -21.9% | 101,326 | 0.0% | 0.01% | -18.2% |
| Q2 2015 | $4,191,000 | -7.9% | 101,326 | 0.0% | 0.01% | -8.3% |
| Q1 2015 | $4,552,000 | -40.0% | 101,326 | -50.0% | 0.01% | +20.0% |
| Q4 2014 | $7,584,000 | +114.4% | 202,652 | +100.0% | 0.01% | +11.1% |
| Q3 2014 | $3,538,000 | -1.0% | 101,326 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $3,575,000 | +8.3% | 101,326 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $3,302,000 | -23.6% | 101,326 | -1.3% | 0.01% | -18.2% |
| Q4 2013 | $4,324,000 | +3.5% | 102,626 | -2.0% | 0.01% | 0.0% |
| Q3 2013 | $4,176,000 | -5.9% | 104,726 | -2.4% | 0.01% | -8.3% |
| Q2 2013 | $4,438,000 | – | 107,326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |